The DOI matches its DataCite record; 11 of the 11 references it cites were found in a registry or an index.
AtomNet: A Deep Convolutional Neural Network for Bioactivity Prediction in Structure-based Drug Discovery
Abstract
Deep convolutional neural networks comprise a subclass of deep neural networks (DNN) with a constrained architecture that leverages the spatial and temporal structure of the domain they model. Convolutional networks achieve the best predictive performance in areas such as speech and image recognition by hierarchically composing simple local features into complex models. Although DNNs have been used in drug discovery for QSAR and ligand-based bioactivity predictions, none of these models have benefited from this powerful convolutional architecture. This paper introduces AtomNet, the first structure-based, deep convolutional neural network designed to predict the bioactivity of small molecules for drug discovery applications. We demonstrate how to apply the convolutional concepts of feature locality and hierarchical composition to the modeling of bioactivity and chemical interactions. In further contrast to existing DNN techniques, we show that AtomNet's application of local convolutional filters to structural target information successfully predicts new active molecules for targets with no previously known modulators. Finally, we show that AtomNet outperforms previous docking approaches on a diverse set of benchmarks by a large margin, achieving an AUC greater than 0.9 on 57.8% of the targets in the DUDE benchmark.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
AtomNet, a deep CNN, outperforms conventional docking models in accuracy with an AUC of 0.9 or more for 58% of targets.
“For instance, Wallach and Dzamba build AtomNet, a deep CNN to predict the bioactivity of small molecule drugs for drug discovery applications. The authors showed that AtomNet outperforms conventional docking models in relation to accuracy with an AUC (area under the curve) of 0.9 or more for 58% of the targets [25].”
From The rise of artificial intelligence in healthcare applications (2020) · cites this paper as [25]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ImageNet classification with deep convolutional neural networks
Krizhevsky, A., Sutskever, I., & Hinton, G. E. (2017) · Communications of the ACM · doi:10.1145/3065386 · Cited by 112,155
LeCun, Y., Bengio, Y., & Hinton, G. (2015) · Nature · doi:10.1038/nature14539 · Cited by 84,126
Trott, O., & Olson, A. J. (2010) · Journal of Computational Chemistry · doi:10.1002/jcc.21334 · Cited by 38,412
Hinton, G., Deng, L., Yu, D., Dahl, G., Mohamed, A.-R., Jaitly, N., Senior, A., Vanhoucke, V., Nguyen, P., Sainath, T., et al. (2012) · IEEE Signal Processing Magazine · doi:10.1109/msp.2012.2205597 · Cited by 10,260
ADADELTA: An Adaptive Learning Rate Method
Zeiler, M. D. (2012) · arXiv · doi:10.48550/arxiv.1212.5701 · Cited by 5,322
ZINC − A Free Database of Commercially Available Compounds for Virtual Screening
Irwin, J. J., & Shoichet, B. K. (2005) · Journal of Chemical Information and Modeling · doi:10.1021/ci049714+ · Cited by 4,058
Directory of useful decoys, enhanced (DUD-E): better ligands and decoys for better benchmarking.
Mysinger, M. M., Carchia, M., Irwin, J. J., & Shoichet, B. K. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300687e · Cited by 2,412
Wang, L., Wu, Y., Deng, Y., Kim, B., Pierce, L., Krilov, G., Lupyan, D., Robinson, S., Dahlgren, M. K., Greenwood, J., et al. (2015) · Journal of the American Chemical Society · doi:10.1021/ja512751q · Cited by 1,313
DeepTox: toxicity prediction using deep learning
Mayr, A., Klambauer, G., Unterthiner, T., & Hochreiter, S. (2016) · Frontiers in Environmental Science · doi:10.3389/fenvs.2015.00080 · Cited by 1,081
Beware of machine learning-based scoring functions-on the danger of developing black boxes.
Gabel, J., Desaphy, J., & Rognan, D. (2014) · Journal of Chemical Information and Modeling · doi:10.1021/ci500406k · Cited by 143
Lagarde, N., Zagury, J.-F., & Montes, M. (2015) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5b00090 · Cited by 85
Flagged first, then by citations
Research works printed but not linked: 30
- D. B. Kitchen, H. Decornez, J. R. Furr, and J. Bajorath, "Docking and scoring in virtual screen- ing for drug discovery: methods and applications.," Nat. Rev. Drug Discov., vol. 3, no. 11, pp. 935-949, 2004.
- C. Szegedy, W. Liu, Y. Jia, P. Sermanet, S. Reed, D. Anguelov, D. Erhan, V. Vanhoucke, and A. Rabinovich, "Going deeper with convolutions," CoRR, vol. abs/1409.4842, 2014. · arXiv
- J. Yosinski, J. Clune, A. Nguyen, T. Fuchs, and H. Lipson, "Understanding neural networks through deep visualization," arXiv preprint arXiv:1506.06579, 2015. · arXiv
- C. Bissantz, B. Kuhn, and M. Stahl, "A medicinal chemists guide to molecular interactions," Journal of Medicinal Chemistry, vol. 53, no. 14, pp. 5061-5084, 2010.
- G. E. Dahl, N. Jaitly, and R. Salakhutdinov, "Multi-task neural networks for QSAR predic- tions," CoRR, vol. abs/1406.1231, 2014. · arXiv
- J. Ma, R. P. Sheridan, A. Liaw, G. E. Dahl, and V. Svetnik, "Deep neural nets as a method for quantitative structureactivity relationships," Journal of Chemical Information and Modeling, vol. 55, no. 2, pp. 263-274, 2015.
- B. Ramsundar, S. Kearnes, P. Riley, D. Webster, D. Konerding, and V. Pande, "Massively Multitask Networks for Drug Discovery," ArXiv e-prints, Feb. 2015.
- Y. Wang, J. Xiao, T. O. Suzek, J. Zhang, J. Wang, Z. Zhou, L. Han, K. Karapetyan, S. Dracheva, B. A. Shoemaker, E. Bolton, A. Gindulyte, and S. H. Bryant, "Pubchem's bioassay database," Nucleic Acids Research, vol. 40, no. D1, pp. D400-D412, 2012.
- A. P. Bento, A. Gaulton, A. Hersey, L. J. Bellis, J. Chambers, M. Davies, F. A. Krger, Y. Light, L. Mak, S. McGlinchey, M. Nowotka, G. Papadatos, R. Santos, and J. P. Overington, "The chembl bioactivity database: an update," Nucleic Acids Research, vol. 42, no. D1, pp. D1083- D1090, 2014.
- S. G. Rohrer and K. Baumann, "Maximum unbiased validation (muv) data sets for virtual screening based on pubchem bioactivity data," Journal of Chemical Information and Modeling, vol. 49, no. 2, pp. 169-184, 2009.
- J. Xia, H. Jin, Z. Liu, L. Zhang, and X. S. Wang, "An unbiased method to build benchmark- ing sets for ligand-based virtual screening and its application to gpcrs," Journal of Chemical Information and Modeling, vol. 54, no. 5, pp. 1433-1450, 2014.
- D. Rogers and M. Hahn, "Extended-connectivity fingerprints," Journal of Chemical Informa- tion and Modeling, vol. 50, no. 5, pp. 742-754, 2010.
- Y. Hu, N. Furtmann, M. Gtschow, and J. Bajorath, "Systematic identification and classification of three-dimensional activity cliffs," Journal of Chemical Information and Modeling, vol. 52, no. 6, pp. 1490-1498, 2012.
- I. Wallach and R. Lilien, "Virtual Decoy Sets for Molecular Docking Benchmarks," J Chem. Inf. and Model., vol. 51, no. 2, pp. 196-202, 2011.
- J. B. Baell and G. A. Holloway, "New substructure filters for removal of pan assay interference compounds (pains) from screening libraries and for their exclusion in bioassays," Journal of Medicinal Chemistry, vol. 53, no. 7, pp. 2719-2740, 2010.
- R. F. Bruns and I. A. Watson, "Rules for identifying potentially reactive or promiscuous com- pounds," Journal of Medicinal Chemistry, vol. 55, no. 22, pp. 9763-9772, 2012.
- T. U. Consortium, "Uniprot: a hub for protein information," Nucleic Acids Research, vol. 43, no. D1, pp. D204-D212, 2015.
- G. W. Bemis and M. A. Murcko, "The properties of known drugs. 1. molecular frameworks," Journal of Medicinal Chemistry, vol. 39, no. 15, pp. 2887-2893, 1996.
- V. Nair and G. E. Hinton, "Rectified linear units improve restricted boltzmann machines," in Proceedings of the 27th International Conference on Machine Learning (ICML-10), June 21- 24, 2010, Haifa, Israel, pp. 807-814, 2010.
- M. Hendlich, F. Rippmann, and G. Barnickel, "Ligsite: automatic and efficient detection of potential small molecule-binding sites in proteins.," J. Mol. Graph. Model., vol. 15, no. 6, 1997.
- C. Da and D. Kireev, "Structural proteinligand interaction fingerprints (splif) for structure- based virtual screening: Method and benchmark study," Journal of Chemical Information and Modeling, vol. 54, no. 9, pp. 2555-2561, 2014.
- Z. Deng, C. Chuaqui, and J. Singh, "Structural interaction fingerprint (SIFt): a novel method for analyzing three-dimensional protein-ligand binding interactions.," J. Med. Chem., vol. 47, no. 2, pp. 337-344, 2004.
- V. I. Prez-Nueno, O. Rabal, J. I. Borrell, and J. Teixid, "Apif: A new interaction fingerprint based on atom pairs and its application to virtual screening," Journal of Chemical Information and Modeling, vol. 49, no. 5, pp. 1245-1260, 2009.
- D. E. Rumelhart, G. E. Hinton, and R. J. Williams, "Neurocomputing: Foundations of re- search," ch. Learning Representations by Back-propagating Errors, pp. 696-699, Cambridge, MA, USA: MIT Press, 1988.
- D. R. Koes, M. P. Baumgartner, and C. J. Camacho, "Lessons learned in empirical scoring with smina from the csar 2011 benchmarking exercise," Journal of Chemical Information and Modeling, vol. 53, no. 8, pp. 1893-1904, 2013.
- M. M. Mysinger and B. K. Shoichet, "Rapid context-dependent ligand desolvation in molecular docking," Journal of Chemical Information and Modeling, vol. 50, no. 9, pp. 1561-1573, 2010.
- R. Spitzer and A. Jain, "Surflex-dock: Docking benchmarks and real-world application," Jour- nal of Computer-Aided Molecular Design, vol. 26, no. 6, pp. 687-699, 2012.
- R. Coleman, T. Sterling, and D. Weiss, "Sampl4 & dock3.7: lessons for automated docking procedures," Journal of Computer-Aided Molecular Design, vol. 28, no. 3, pp. 201-209, 2014.
- R. G. Coleman, M. Carchia, T. Sterling, J. J. Irwin, and B. K. Shoichet, "Ligand pose and orientational sampling in molecular docking," PLoS ONE, vol. 8, p. e75992, 10 2013.
- W. J. Allen, T. E. Balius, S. Mukherjee, S. R. Brozell, D. T. Moustakas, P. T. Lang, D. A. Case, I. D. Kuntz, and R. C. Rizzo, "Dock 6: Impact of new features and current docking performance," Journal of Computational Chemistry, vol. 36, no. 15, pp. 1132-1156, 2015.
Cited by
Sorted by citations
MoleculeNet: a benchmark for molecular machine learning
Wu, Z., Ramsundar, B., Feinberg, E. N., Gomes, J., Geniesse, C., Pappu, A. S., Leswing, K., & Pande, V. (2018) · Chemical Science · doi:10.1039/c7sc02664a · Cited by 3,107
Opportunities and obstacles for deep learning in biology and medicine
Ching, T., Himmelstein, D. S., Beaulieu-Jones, B. K., Kalinin, A. A., Do, B. T., Way, G. P., Ferrero, E., Agapow, P.-M., Zietz, M., Hoffman, M. M., et al. (2018) · Journal of The Royal Society Interface · doi:10.1098/rsif.2017.0387 · Cited by 2,310
The rise of deep learning in drug discovery
Chen, H., Engkvist, O., Wang, Y., Olivecrona, M., & Blaschke, T. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.01.039 · Cited by 1,770
Molecular graph convolutions: moving beyond fingerprints
Kearnes, S., McCloskey, K., Berndl, M., Pande, V., & Riley, P. (2016) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-016-9938-8 · Cited by 1,631
The rise of artificial intelligence in healthcare applications
Bohr, A., & Memarzadeh, K. (2020) · Artificial Intelligence in Healthcare · doi:10.1016/b978-0-12-818438-7.00002-2 · Cited by 1,636
Machine learning in materials science
Wei, J., Chu, X., Sun, X., Xu, K., Deng, H., Chen, J., Wei, Z., & Lei, M. (2019) · InfoMat · doi:10.1002/inf2.12028 · Cited by 1,069
Drug discovery with explainable artificial intelligence
Jiménez-Luna, J., Grisoni, F., & Schneider, G. (2020) · Nature Machine Intelligence · doi:10.1038/s42256-020-00236-4 · Cited by 1,063
Molecular Sets (MOSES): A Benchmarking Platform for Molecular Generation Models
Polykovskiy, D., Zhebrak, A., Sanchez-Lengeling, B., Golovanov, S., Tatanov, O., Belyaev, S., Kurbanov, R., Artamonov, A., Aladinskiy, V., Veselov, M., et al. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.565644 · Cited by 849
Machine learning unifies the modeling of materials and molecules
Bartók, A. P., De, S., Poelking, C., Bernstein, N., Kermode, J. R., Csányi, G., & Ceriotti, M. (2017) · Science Advances · doi:10.1126/sciadv.1701816 · Cited by 764
Tsubaki, M., Tomii, K., & Sese, J. (2019) · Bioinformatics · doi:10.1093/bioinformatics/bty535 · Cited by 688
Artificial intelligence in COVID-19 drug repurposing
Zhou, Y., Wang, F., Tang, J., Nussinov, R., & Cheng, F. (2020) · The Lancet Digital Health · doi:10.1016/s2589-7500(20)30192-8 · Cited by 636
Mater, A. C., & Coote, M. L. (2019) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.9b00266 · Cited by 565
Graph Convolutional Neural Networks for Predicting Drug-Target Interactions
Torng, W., & Altman, R. B. (2019) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.9b00628 · Cited by 371
Kadurin, A., Aliper, A., Kazennov, A., Mamoshina, P., Vanhaelen, Q., Khrabrov, K., & Zhavoronkov, A. (2017) · Oncotarget · doi:10.18632/oncotarget.14073 · Cited by 350
Deep learning in drug discovery: opportunities, challenges and future prospects
Lavecchia, A. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2019.07.006 · Cited by 353
Guedes, I. A., Pereira, F. S. S., & Dardenne, L. E. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01089 · Cited by 331
Cang, Z., & Wei, G.-W. (2017) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1005690 · Cited by 330
Entangled Conditional Adversarial Autoencoder for de Novo Drug Discovery
Polykovskiy, D., Zhebrak, A., Vetrov, D., Ivanenkov, Y., Aladinskiy, V., Mamoshina, P., Bozdaganyan, M., Aliper, A., Zhavoronkov, A., & Kadurin, A. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00839 · Cited by 278
Cang, Z., Mu, L., & Wei, G.-W. (2018) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1005929 · Cited by 257
Big data in basic and translational cancer research
Jiang, P., Sinha, S., Aldape, K., Hannenhalli, S., Sahinalp, C., & Ruppin, E. (2022) · Nature Reviews Cancer · doi:10.1038/s41568-022-00502-0 · Cited by 254
Shape-Based Generative Modeling for de Novo Drug Design
Skalic, M., Jiménez, J., Sabbadin, D., & De Fabritiis, G. (2019) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.8b00706 · Cited by 229
Atomic convolutional networks for predicting protein-ligand binding affinity
Gomes, J., Ramsundar, B., Feinberg, E. N., & Pande, V. S. (2017) · arXiv · doi:10.48550/arxiv.1703.10603 · Cited by 150
3D deep convolutional neural networks for amino acid environment similarity analysis
Torng, W., & Altman, R. B. (2017) · BMC Bioinformatics · doi:10.1186/s12859-017-1702-0 · Cited by 142
DeepCPI: A Deep Learning-Based Framework for Large-Scale in Silico Drug Screening
Wan, F., Zhu, Y., Hu, H., Dai, A., Cai, X., Chen, L., Gong, H., Xia, T., Yang, D., Wang, M.-W., et al. (2019) · Genomics, Proteomics & Bioinformatics · doi:10.1016/j.gpb.2019.04.003 · Cited by 92
Explainable Deep Relational Networks for Predicting Compound-Protein Affinities and Contacts
Karimi, M., Wu, D., Wang, Z., & Shen, Y. (2019) · doi:10.1101/2019.12.28.890103 · Cited by 64
Saikin, S. K., Kreisbeck, C., Sheberla, D., Becker, J. S., & Aspuru-Guzik, A. (2019) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2019.1546690 · Cited by 63
Structural Learning of Proteins Using Graph Convolutional Neural Networks
Zamora-Resendiz, R., & Crivelli, S. (2019) · doi:10.1101/610444 · Cited by 37
Zhou, H., Cao, H., & Skolnick, J. (2018) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.8b00309 · Cited by 39
FRAGSITE: A Fragment-Based Approach for Virtual Ligand Screening
Zhou, H., Cao, H., & Skolnick, J. (2021) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.0c01160 · Cited by 32
How Does AI Improve Human Decision-Making? Evidence from the AI-Powered Go Program
Choi, S., Kim, N., Kim, J., & Kang, H. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3893835 · Cited by 30
TinySpeech: Attention Condensers for Deep Speech Recognition Neural Networks on Edge Devices
Wong, A., Famouri, M., Pavlova, M., & Surana, S. (2020) · arXiv · doi:10.48550/arxiv.2008.04245 · Cited by 27
Pedicone, C., Fernandes, S., Matera, A., Meyer, S. T., Loh, S., Ha, J.-H., Bernard, D., Chisholm, J. D., Paolicelli, R. C., & Kerr, W. G. (2022) · iScience · doi:10.1016/j.isci.2022.104170 · Cited by 26
Metadata
- Authors
- Wallach, I., Dzamba, M., & Heifets, A.
- Venue
- arXiv
- Publisher
- arXiv
- Published
- 2015
- arXiv
- 1510.02855
- References
- 11
- Type
- Preprint
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review